Vincristine Sulfate Liposomes Injection

DRUG2 trials

Sponsors

Acrotech Biopharma Inc.

Conditions

Acute Lymphoblastic LeukemiaMalignant Melanoma

Phase 1

Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

CompletedNCT00144963

Acrotech Biopharma Inc.Acute Lymphoblastic Leukemia

Start: 2002-07-31End: 2006-08-31Updated: 2019-12-12

Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction

CompletedNCT00145041

Acrotech Biopharma Inc.Malignant Melanoma

Start: 2005-02-28End: 2007-11-30Updated: 2019-12-12